| |
 |
 |
 |
 |
 |
 |
 |
February 10, 2003
| Key Personnel
Change at AnGes MG |
 |
|
|
AnGes MG Inc. has announced a tentative decision
at the Board of Directors meeting convened February 10, 2003
to grant a key personnel change at its top. This will be finalized
and implemented at the Board of Directors Meeting to be convened
after the General Shareholders Meeting on March 27, 2003.
1.Personnel Change
Name
(Date of birth) |
Effective
date |
Position
title |
| Pre-change |
Post-change |
Kensuke TOMITA
(January 8, 1949) |
March 27, 2003
(resignation from post) |
Chairman of the
Board of Directors |
Honorary Advisor |
|
2.Reason of Personnel Change
Kensuke TOMITA is one of the leading private sector experts
in Japan's gene therapy concerned certification. He has successfully
held prominent positions at AnGes MG including President/CEO
and Chairmen of the Board of Directors, with a track record
of distinguished business performance achievements including:
conclusion of R&D and marketing agreements with ISHIHARA
SANGYO KAISHA, LTD. and Daiichi Pharmaceutical Co., Ltd. Considering
the company's listing on the Tokyo Stock Exchange Mothers as
a milestone, he put forth a request to resign from the Board
of Directors, in order to step out of the corporate limelight
of the upper management echelons.
The company has reluctantly bowed to his adamant request since
it is most confident that the rest of the management team, headed
by President & CEO Ei Yamada, is already proving itself
up to the task of steering the company's fortunes.
3.Perspective for the Future
Kensuke Tomita is designated to become an Honorary Advisor to
the company after his resignation from the Board of Directors,
in order to enhance the company's management backbone out of
the spotlight.
AnGes MG will continue its corporate organizational restructuring
in order to realize optimal management policies as a leading
venture company in the bio-science sector. |
|
|
